356 related articles for article (PubMed ID: 25952491)
21. Procarbazine, lomustine and vincristine or temozolomide: which is the better regimen?
Lassman AB
CNS Oncol; 2015; 4(5):341-6. PubMed ID: 26544062
[TBL] [Abstract][Full Text] [Related]
22. New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951.
Gorlia T; Delattre JY; Brandes AA; Kros JM; Taphoorn MJ; Kouwenhoven MC; Bernsen HJ; Frénay M; Tijssen CC; Lacombe D; van den Bent MJ
Eur J Cancer; 2013 Nov; 49(16):3477-85. PubMed ID: 23896377
[TBL] [Abstract][Full Text] [Related]
23. The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy.
Glass J; Hochberg FH; Gruber ML; Louis DN; Smith D; Rattner B
J Neurosurg; 1992 May; 76(5):741-5. PubMed ID: 1564535
[TBL] [Abstract][Full Text] [Related]
24. [Management of gliomas].
Lévy S; Chapet S; Mazeron JJ
Cancer Radiother; 2014 Oct; 18(5-6):461-7. PubMed ID: 25201633
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.
Cairncross G; Macdonald D; Ludwin S; Lee D; Cascino T; Buckner J; Fulton D; Dropcho E; Stewart D; Schold C
J Clin Oncol; 1994 Oct; 12(10):2013-21. PubMed ID: 7931469
[TBL] [Abstract][Full Text] [Related]
26. Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial.
Chang SM; Prados MD; Yung WK; Fine H; Junck L; Greenberg H; Robins HI; Mehta M; Fink KL; Jaeckle KA; Kuhn J; Hess K; Schold C
Cancer; 2004 Apr; 100(8):1712-6. PubMed ID: 15073861
[TBL] [Abstract][Full Text] [Related]
27. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R
Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438
[TBL] [Abstract][Full Text] [Related]
28. Sunitinib Malate plus Lomustine for Patients with Temozolomide-refractory Recurrent Anaplastic or Low-grade Glioma.
Duerinck J; Du Four S; Sander W; Van Binst AM; Everaert H; Michotte A; Hau P; Neyns B
Anticancer Res; 2015 Oct; 35(10):5551-7. PubMed ID: 26408725
[TBL] [Abstract][Full Text] [Related]
29. Radiotherapy plus temozolomide or PCV in patients with anaplastic oligodendroglioma 1p19q codeleted.
Gonzalez-Aguilar A; Reyes-Moreno I; Peiro-Osuna RP; Hernandez-Hernandez A; Gutierrez-Aceves A; Santos-Zambrano J; Guerrero-Juarez V; Lopez-Martinez M; Castro-Martinez E
Rev Neurol; 2018 Oct; 67(8):293-297. PubMed ID: 30289152
[TBL] [Abstract][Full Text] [Related]
30. Aggressive oligodendroglioma: a chemosensitive tumor.
Cairncross JG; Macdonald DR; Ramsay DA
Neurosurgery; 1992 Jul; 31(1):78-82. PubMed ID: 1641113
[TBL] [Abstract][Full Text] [Related]
31. 1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment.
Kouwenhoven MC; Kros JM; French PJ; Biemond-ter Stege EM; Graveland WJ; Taphoorn MJ; Brandes AA; van den Bent MJ
Eur J Cancer; 2006 Oct; 42(15):2499-503. PubMed ID: 16914310
[TBL] [Abstract][Full Text] [Related]
32. PCV for anaplastic oligodendrogliomas: back to the future or a step backwards? A point/counterpoint discussion.
Villano JL; Wen PY; Lee EQ; Nayak L; Reardon DA; Rosenfeld MR
J Neurooncol; 2013 May; 113(1):143-7. PubMed ID: 23479035
[No Abstract] [Full Text] [Related]
33. PC or PCV, That Is the Question: Primary Anaplastic Oligodendroglial Tumors Treated with Procarbazine and CCNU With and Without Vincristine.
Webre C; Shonka N; Smith L; Liu D; De Groot J
Anticancer Res; 2015 Oct; 35(10):5467-72. PubMed ID: 26408710
[TBL] [Abstract][Full Text] [Related]
34. Aggressive oligodendroglioma: a chemosensitive tumor.
Cairncross JG
Recent Results Cancer Res; 1994; 135():127-33. PubMed ID: 8047688
[No Abstract] [Full Text] [Related]
35. [Favourable result for temozolomide in recurrent high-grade glioma].
Taal W; van der Rijt CD; Sillevis Smitt PA; Kros JM; van Heuvel I; Enting RH; van den Bent MJ
Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1393-9. PubMed ID: 15997692
[TBL] [Abstract][Full Text] [Related]
36. Oligodendroglial tumor chemotherapy using "decreased-dose-intensity" PCV: a Singapore experience.
Ty AU; See SJ; Rao JP; Khoo JB; Wong MC
Neurology; 2006 Jan; 66(2):247-9. PubMed ID: 16434664
[TBL] [Abstract][Full Text] [Related]
37. Radiotherapy plus concurrent and adjuvant procarbazine, lomustine, and vincristine chemotherapy for patients with malignant glioma.
Yang SH; Hong YK; Yoon SC; Kim BS; Lee YS; Lee TK; Lee KS; Jeun SS; Kim MC; Park CK
Oncol Rep; 2007 Jun; 17(6):1359-64. PubMed ID: 17487391
[TBL] [Abstract][Full Text] [Related]
38. Neuro-oncology: the growing role of chemotherapy in glioma.
Carpentier AF
Lancet Neurol; 2005 Jan; 4(1):4-5. PubMed ID: 15620846
[No Abstract] [Full Text] [Related]
39. Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trial.
Taphoorn MJ; van den Bent MJ; Mauer ME; Coens C; Delattre JY; Brandes AA; Sillevis Smitt PA; Bernsen HJ; Frénay M; Tijssen CC; Lacombe D; Allgeier A; Bottomley A;
J Clin Oncol; 2007 Dec; 25(36):5723-30. PubMed ID: 18089866
[TBL] [Abstract][Full Text] [Related]
40. [Pattern of care of high-grade gliomas].
Laigle-Donadey F; Sanson M
Rev Prat; 2006 Oct; 56(16):1779-86. PubMed ID: 17315503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
